Karyopharm Therapeutics | 유동 부채





유동 부채 변화 날짜
AbbVie USD 39.39B 376M 2025-09
Abbott USD 14.58B 1.14B 2025-09
Amgen USD 25.49B 3.7B 2025-12
AstraZeneca USD 34.05B 518M 2025-09
BioCryst Pharmaceuticals USD 190.24M 13.08M 2025-09
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Eli Lilly USD 40.14B 1.12B 2025-09
Enanta Pharmaceuticals USD 48.56M 4.01M 2025-09
GlaxoSmithKline GBP 21.39B 57M 2025-12
Incyte USD 1.52B 176.44M 2025-12
J&J USD 50.87B 3.31B 2025-09
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
MacroGenics USD 44.47M 5.47M 2025-09
Merck USD 28.63B 2.59B 2025-09
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Novartis USD 32B 286M 2025-09
Novartis USD 32B 286M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Takeda JPY 2.61T 470.53B 2025-12
Tectonic Therapeutic USD 9.37M 1.99M 2025-09
TG Therapeutics USD 156.81M 15.08M 2025-09
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Xencor USD 86.48M 9.6M 2025-09


Karyopharm Therapeutics 유동 부채 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Feb 2026.